Ophthotech Raises $175 Million to Finance the Pivotal Phase 3 Program for

Ophthotech Raises 5 Million to Finance the Pivotal Phase 3 Program for

Filed under: drug treatment programs in san francisco

Ophthotech Corporation today announced that it has raised $ 175 million to finance a global Phase 3 clinical program of its lead compound Fovista(TM), an anti-platelet-derived growth factor (PDGF), in combination with anti-VEGF therapy for the treatment …
Read more on MarketWatch (press release)

 

Legally unsound? A book meant to assist doctors becomes a weapon in the courts

Filed under: drug treatment programs in san francisco

Three members of Occupy Psychiatry protest the American Psychiatric Association at their annual conference in San Francisco last week. Walter Madden had a secret. He and … Those diagnoses can help people duck criminal sentences, subject them to …
Read more on The Verge

 

Control of polypharmacy, drug interactions key components in treatment of

Filed under: drug treatment programs in san francisco

SAN FRANCISCO – American Psychiatric Association Scientific Program Committee member Iqbal Ahmed, MD, offers his perspective on a symposium he participated in, “Perils and Pitfalls Related to Geriatric Psychopharmacology.” This session offered a …
Read more on Healio

 

Titan Pharmaceuticals Announces Amendment to Partnership With Braeburn

Filed under: drug treatment programs in san francisco

SOUTH SAN FRANCISCO, CA–(Marketwired – May 29, 2013) – Titan Pharmaceuticals, Inc. ( OTCBB : TTNP) announced today that it has entered into an amendment to its license agreement with Braeburn Pharmaceuticals Sprl for the exclusive commercialization …
Read more on Marketwire (press release)